Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block in Cerebral Small Vessel Disease Patients With Dysphagia and Cognitive Impairment

NCT06176404 is registered in ClinicalTrials.gov with Zeng Changhao as lead sponsor.

NCT NCT06176404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block in Cerebral Small Vessel Disease Patients With Dysphagia and Cognitive Impairment
Lead sponsor
Zeng Changhao
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
May 31, 2023
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel diseases, cognitive impairment, dysphagia